NEW YORK, June 7, 2026 — IQM is not interesting this week because it filed another form. It matters because the Finnish quantum-computing builder has turned a vague European deep-tech listing story into a more concrete public-market test: PIPE commitments now top $146 million after Ilmarinen joined the book, the company still says the transaction values IQM at about $1.8 billion pre-money, and the June 5 final prospectus shows exactly what public investors would inherit: ADSs, a large warrant layer and a redemption-sensitive SPAC close.

There is more operating proof here than in many quantum-market stories. In its May 14 filing announcement, IQM said it had sold 23 systems, delivered 15, and built more than 30 computers, while also claiming placements with four of the top 10 supercomputing centres. That does not make the business mature, but it does separate IQM from earlier public quantum entrants that came to market with more roadmap than installed base. The company also used an April enterprise-customer announcement in Poland to show that the customer set is not purely academic or sovereign.

The financial texture is still harsh. According to the June 3 amended F-4/A, IQM generated €31.3 million of revenue in 2025, up 91% from 2024, while posting a roughly €54.1 million loss before income tax. That combination is why this deal deserves attention: the top line is moving, but the company is still asking public investors to finance a business that remains deeply loss-making while the technology race stays capital intensive.

The structure is where the story gets more specific. The 424B3 prospectus covers up to 21.625 million IQM shares represented by ADSs, 14.075 million warrants, 14.075 million ADSs issuable on warrant exercise, and the resale of up to 4.375 million shares by selling holders. There is no traditional underwriting syndicate giving this transaction shape; instead, the market is being asked to underwrite a merger closing, a private placement and an inherited warrant stack. IPOGrid reads that as a meaningful distinction. This may trade like a new issue, but economically it is still a de-SPAC with familiar dilution and redemption mechanics.

The PIPE upgrade helps. The original February launch materials highlighted a $134 million PIPE at $10 per share; by June 2, IQM and Real Asset Acquisition said commitments had risen to more than $146 million. That is one of the better demand signals on the calendar, especially for a company in a sector where most investors still debate commercialization timelines rather than delivery schedules. Our interpretation is that the PIPE matters less as a headline cash number than as evidence that institutions were willing to reopen the book after the initial announcement.

Still, the deal is not finished. The proxy card filed as Exhibit 99.1 to the amended F-4/A still leaves the extraordinary general meeting date blank, a useful reminder that the closing step is pending even after the final prospectus. The same company materials repeatedly warn that redemptions could reduce available cash, and the no-redemption cash presentation is doing a lot of work in the marketing. The reviewer’s concern is not that IQM lacks technical ambition; it is that public investors are still being asked to bridge a meaningful gap between a promising installed base and a self-funding operating model.

IQM has also not come to market empty-handed. In March it disclosed a €50 million financing package from funds and accounts managed by BlackRock, which suggests this is a scaling balance sheet, not a last-minute rescue. But the company’s own risk language in its May 14 filing announcement flags concentration of revenue in government or state-funded contracts, continued net losses and the possibility of needing more capital. We would frame that as the central trade-off: IQM may be one of the more credible hardware-backed quantum stories headed toward public markets, yet credibility does not remove the financing burden that comes with building the category.

That is why IQM deserves the spotlight now. If the transaction closes, the company would advance its case to be the first listed European quantum pure play on a major U.S. exchange, with a planned Helsinki listing still part of the ambition in company materials. But what investors are really being asked to buy is not the slogan. It is a real revenue line, a real delivery record, and a capital structure that remains unmistakably SPAC-shaped even after a stronger PIPE.